Cargando…
Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular Disease
Autor principal: | Kobayashi, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100469/ https://www.ncbi.nlm.nih.gov/pubmed/33790128 http://dx.doi.org/10.5551/jat.ED170 |
Ejemplares similares
-
Which is the Best Predictor for the Development of Atherosclerosis Among Circulating Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase?
por: Kobayashi, Junji
Publicado: (2019) -
Prevention of Cardiovascular Events with Pitavastatin is Associated with Increased Serum Lipoprotein Lipase Mass Level: Subgroup Analysis of the TOHO-LIP
por: Nagayama, Daiji, et al.
Publicado: (2022) -
Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia
por: Mita, Tomoya, et al.
Publicado: (2013) -
Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats
por: Koladiya, Rajeshkumar U, et al.
Publicado: (2008) -
Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
por: Han, Hui, et al.
Publicado: (2019)